Press Releases

Adcentrx Therapeutics Announces Completion of $50M Series A Financing Led By CBC Group To Accelerate Next-Generation Conjugate Drugs Research & Development

April 28, 2021, Shanghai, China, San Diego, California. Adcentrx Therapeutics (“Adcentrx”), a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (“ADC”) therapeutic development, announced the closing of $50m Series A financing to power the development of next generation ADC for improving patient treatment options. This round of financing was led by CBC Group (“CBC”). Zoo Capital, Boyu Capital’s venture arm, also joined this round.
Read More